Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 198.82 million compared to INR 145.47 million a year ago. Revenue was INR 199.63 million compared to INR 149.29 million a year ago. Net loss was INR 2.49 million compared to INR 11.09 million a year ago. Basic loss per share from continuing operations was INR 0.01 compared to INR 0.04 a year ago. Diluted loss per share from continuing operations was INR 0.01 compared to INR 0.04 a year ago.